In our research, Fas or BA treatment increased the number of Nissl bodies, indicating the integrity of CA1 region in the hippocampus, improved neuronal atrophy, and attenuated neuronal apoptosis in the hippocampus of CUMS- and LPS-induced animal models of depression. This evidence concerns the gene FAS and depressive symptom measurement.